PRISM Mid-Day Movers: Women's Health Breakthrough and Crypto Challenges

Dare Bioscience Soars 89% on Ovaprene Phase 3 Results
Dare Bioscience Inc. (DARE) rallied 88.87% to lead the PRISM Emerging Women's Health Index after announcing positive interim Phase 3 results for its novel hormone-free contraceptive, Ovaprene. The product has no FDA-approved equivalents and demonstrated efficacy consistent with earlier studies and favorable tolerability. Approximately 9% of study participants experienced pregnancy, aligning with expectations while no serious safety issues emerged. With the potential to become the first FDA-approved product in its category, Ovaprene may offer a much-needed alternative to hormonal birth control. Market enthusiasm has also been fueled by Dare's licensing agreement with Bayer, which holds exclusive U.S. commercialization rights upon successful trial completion and regulatory approval.

Soluna Slides 20% Despite Business Expansion and Positive Outlook
Soluna Holdings, Inc. (SLNH) dropped 19.64%, dragging down the PRISM Emerging Crypto Mining Index, despite releasing a shareholder letter and monthly update highlighting operational progress. The company touted growth across its renewable-powered data centers used for Bitcoin mining and AI compute, and revealed a 2.8 GW development pipeline. June highlights included expanded partnerships with Compass Mining and Blockware, continued rollout at its flagship Project Dorothy 2 site, and the upcoming launch of Project Kati. The downward movement comes as Bitcoin and the broader cryptocurrency market are falling after reaching new all time highs.

Other PRISM Mid-Day Movers:

• Cumberland Pharmaceuticals Inc. (CPIX) up 20.24%
• BIT Mining Ltd (BTCM) up 17.17%
• ProKidney Corp. (PROK) down 15.42%

The post PRISM Mid-Day Movers: Women's Health Breakthrough and Crypto Challenges appeared first on PRISM MarketView.

COMTEX_467324654/2927/2025-07-14T13:00:34